PCOS and Fertility: Understanding the Link from Diagnosis to Treatment

What Does PCOS Have to Do With Fertility?

The link between PCOS and fertility is not a straight line, but it is well documented. Polycystic ovary syndrome affects an estimated 10% to 13% of women of reproductive age worldwide (the World Health Organization), and it is a leading cause of infertility that works through absent or irregular ovulation (the CDC).

If you have just been diagnosed, or you suspect you might have PCOS, the quiet question underneath is: does this mean I will struggle to get pregnant? PCOS shifts the odds without determining anyone’s individual result.

This post follows that order: diagnosis, mechanism, outcome, and the pathway through testing and treatment.

One note before we begin: this is general health information, not medical advice. Decisions about diagnosis, testing, and treatment belong in a conversation with your clinician.

What Is PCOS? Rethinking the Name and the Diagnosis

Polycystic ovary syndrome is a hormonal and metabolic condition, and its name trips up almost everyone at first. “Polycystic” means “many cysts,” which sounds like a structural problem: growths on the ovaries that might need to be removed. That is not what is happening.

On an ultrasound, ovaries with PCOS often show many small follicles arranged around the edges. Those are not cysts in the surgical sense: they are eggs that began to mature but stalled because the hormonal signals driving maturation were out of balance.

PCOS is also a syndrome rather than a single disease, so it shows up differently from person to person. Some people have regular periods and clearly elevated androgens; others have irregular cycles and polycystic-appearing ovaries without high androgens. That variety is one reason the condition is often missed, and it is why diagnosis follows specific criteria rather than a single test.

The Rotterdam Criteria: Two of Three Features

There is no single blood test that confirms PCOS. Since 2003, clinicians have used the Rotterdam criteria: two of the three features must be present. Both current diagnostic guidelines and the AAFP’s clinical review lay them out the same way:

• Hyperandrogenism: elevated male hormones, shown either on a blood test or through signs such as excess facial or body hair, acne, or hair thinning.
• Oligo-ovulation or anovulation: cycles that are irregular, infrequent, or absent.
• Polycystic ovarian morphology: many small follicles on ultrasound (the original 2003 threshold was 12 or more per ovary, and current guidance uses 20 or more on modern equipment), or an ovarian volume above 10 mL.

Meeting two of the three is enough; not everyone has all three. PCOS is also a diagnosis of exclusion: a clinician rules out look-alike conditions such as thyroid dysfunction, elevated prolactin, or non-classical congenital adrenal hyperplasia before confirming it.

Why the Name “Polycystic” Confuses People

The word “cysts” sends many people into a worry spiral about growths that may need removal. In PCOS, the follicles are a snapshot of stalled egg development, not a structural abnormality. That distinction matters: the real conversation is about hormonal signaling, not about anything growing on your ovaries.

The Mechanism: How PCOS Disrupts Ovulation at the Cellular Level

This is the heart of the connection between PCOS and fertility, and it runs as a chain: insulin resistance leads to high insulin, high insulin drives the ovaries to produce more androgens, excess androgens interrupt egg maturation, ovulation becomes irregular or stops, and the phase after ovulation can become less reliable too.

Insulin resistance means your cells respond to insulin less readily than they should. The pancreas compensates, so blood insulin climbs even when glucose still looks normal. Many people with PCOS have insulin resistance, often before a diabetes diagnosis, which is why metabolic screening appears in a fertility workup, and a clinician can assess the pattern through specialized lab testing.

From Hyperinsulinemia to Ovarian Androgen Excess

Inside the ovary, insulin behaves almost like a second messenger for luteinizing hormone (LH). High insulin amplifies the ovary’s response to LH, and the ovary answers with more testosterone and androstenedione (research decoding androgen excess in PCOS).

At the same time, insulin tells the liver to make less sex hormone-binding globulin (SHBG), the protein that binds up excess testosterone (a review of insulin resistance and hyperandrogenism). With less SHBG circulating, more testosterone stays free and active.

The two effects reinforce each other: more androgens can worsen insulin resistance, which raises insulin further, which pushes androgen production up again (a 2025 model of this cycle). Think of insulin as a volume knob: in PCOS it sits higher than it should, and the ovaries answer by producing more androgens than the system expects.

Follicular Arrest: Why Eggs Do Not Mature

In a typical cycle, a cohort of follicles starts to develop, one becomes dominant, and the rest regress. In PCOS, excess androgens plus altered signals such as anti-Mullerian hormone (AMH) keep any single follicle from taking the lead (a 2024 review of androgen excess in PCOS).

The follicles stop at the small antral stage, which is what the “polycystic” pattern on an ultrasound represents; clinicians call this follicular arrest. Ovulation then does not happen or happens infrequently, and without ovulation there is no egg to meet sperm. That is the most direct line from PCOS to fertility trouble. For background on the hormones involved, our piece on hormones in fertility goes deeper.

The Luteal Phase Defect and the Progesterone Problem

Even when ovulation happens, the second half of the cycle can be less steady. After ovulation, the corpus luteum produces progesterone, which prepares the uterine lining for implantation and supports an early pregnancy.

In PCOS, progesterone levels may be lower or the luteal phase shorter than the rest of the cycle would suggest (a 2023 review of PCOS and recurrent pregnancy loss). This is the subtler fertility effect: the question shifts from whether an egg was released to whether the uterus is ready to support a pregnancy, and it belongs with a clinician to evaluate, not a self-assessment.

What the Research Says About PCOS and Fertility Outcomes

Mechanism tells us what can happen; evidence tells us how often. Plainly: PCOS does not guarantee infertility. Many people with PCOS conceive without treatment, and many more do with help. What PCOS does is shift population-level odds, which is worth understanding rather than treating any statistic as a prediction about you. To separate fact from folklore, see our fertility myths vs facts piece.

Ovulatory Versus Anovulatory Cycles

Not everyone with PCOS is anovulatory. Some ovulate regularly, some irregularly, and some rarely at all. The practical signal is cycle length: cycles that run consistently longer than 35 days usually mean fewer ovulations across a year, and therefore fewer windows in which conception is possible.

Irregular ovulation also makes timing harder, because the textbook 28-day rhythm does not apply. Our guide to ovulation awareness walks through tracking approaches for unpredictable cycles.

Time to Conceive: What the Numbers Show

The arithmetic is simple: fewer ovulations per year means fewer chances for conception, and an anovulatory cycle is a month in which timing did not matter at all. In one large prospective cohort of 1,779 women with PCOS trying to conceive, 37% reached a pregnancy that ended in a term live birth within a year of joining the study, rising to about two thirds over several years of follow-up. Those are study-group figures, not a prediction about you.

Other analyses report that once ovulation is regular, whether on its own or with treatment, live birth rates in PCOS move closer to those seen in people without other fertility factors. That is a population-level observation, not a personal guarantee. Age remains its own variable, so our piece on age and fertility is worth reading alongside this one.

Early Pregnancy Loss and Implantation Risk

This is the part of the conversation that deserves care. A 2024 systematic review in Nature Communications, pooling 106,690 pregnancies, found that people with PCOS have roughly 49% to 53% higher odds of miscarriage than people without the condition, and that analysis informed the 2023 international guideline recommendations published by ASRM.

Researchers think several mechanisms are involved: lower progesterone support after ovulation, changes in the uterine lining from excess androgens, and metabolic factors such as insulin resistance affecting the implantation environment.

Please read that statistic for what it is, not as a forecast. Higher odds at a population level do not mean miscarriage is inevitable, and a pregnancy with PCOS is usually watched more closely. If you have experienced a pregnancy loss, that grief is real, and it is not your fault. Our piece on the emotional side of infertility is a place to find support.

The Fertility Workup: What Happens When You Seek Help

A fertility workup for PCOS pulls on several threads at once. There is no single test, and the process is less intimidating than it sounds.

Typically, a clinician evaluates:

• Whether the PCOS diagnosis meets the Rotterdam criteria, if it is not yet confirmed.
• Ovulation status, often through progesterone testing or several cycles of tracking.
• A semen analysis for your partner, because fertility is a shared factor.
• Tubal patency, to rule out blockages.
• Metabolic screening (glucose, insulin, HbA1c, lipids), since insulin resistance is part of this story.
• Thyroid and prolactin levels, to rule out conditions that mimic PCOS.

Each of those is ordered and interpreted by a professional, not a checklist to run alone. For a fuller walkthrough, our guide to fertility testing covers timing and logistics, and specialized lab testing covers hormones.

Treatment Pathways: How Clinicians Approach Fertility in PCOS

Treatment in PCOS tends to be sequenced: clinicians usually start with the least invasive option that fits your situation and adjust from there. Everything here describes options a clinician evaluates with you, shaped by your age, cycle history, and metabolic picture. None of it is a protocol to begin on your own. For other ways PCOS itself is approached, including hormone-related options, see BHRT for women with PCOS.

Body weight and metabolic health come into this conversation as well, which we cover separately in how weight influences ovulation.

Ovulation Induction: Letrozole as First-Line Therapy

Ovulation induction uses medication to help the ovaries develop and release a mature egg. The 2023 international guideline recommends letrozole as first-line for PCOS (guidance on treating ovulatory dysfunction). It works by temporarily lowering estrogen, which prompts the pituitary to raise follicle-stimulating hormone (FSH) and move follicle growth forward.

In the landmark PPCOS II trial (Legro and colleagues, New England Journal of Medicine, 2014), letrozole produced more live births than clomiphene (27.5% versus 19.1%) with fewer twin pregnancies (3.4% versus 7.4%); a 2025 meta-analysis reached the same result. Those figures describe study groups, not any individual’s odds, and whether ovulation induction fits your situation is a decision your clinician makes with you.

Insulin Sensitizers and Metabolic Support

Because insulin sits upstream in the chain, changing what it does changes what happens downstream. Metformin, an insulin-sensitizing medication, lowers insulin levels, which may reduce ovarian androgen production and improve ovulation frequency. The 2023 international guideline supports it for people with PCOS and insulin resistance, often alongside ovulation induction (ACOG’s PCOS FAQ covers the same ground).

Whether metabolic medication belongs in your plan, and how nutrition fits alongside it, is a clinician’s call. Our article on PCOS nutrition strategies covers the dietary side.

Weight, Lifestyle and Ovulation

Body weight and composition influence insulin resistance, which in turn influences androgens and ovulation. Research associates higher BMI with greater insulin resistance in PCOS, and the international guideline notes that for some people, a modest reduction in body weight is associated with improved ovulation.

It is worth being precise: this is an association observed in studies, not a verdict on anyone’s efforts or choices, and weight is one factor among several. Adjustments to eating, movement, sleep, and stress, made with your provider, can support overall hormonal health. For more, see our pieces on lifestyle changes that can impact fertility and stress and fertility.

Key Takeaways: What This Means for You

In short:

• PCOS is diagnosed through the Rotterdam criteria (two of three features) after similar conditions are ruled out. It is a hormonal and metabolic condition, not a cyst problem.
• The PCOS-to-fertility link runs through insulin resistance, high insulin, ovarian androgen excess, disrupted folliculogenesis, and a less reliable luteal phase.
• The evidence points to longer average time to conceive and higher odds of early pregnancy loss. These are population-level associations, not predictions about you.
• Clinician-directed options exist at every stage, from the workup through ovulation induction, metabolic support, and lifestyle guidance.

If you have PCOS and are thinking about pregnancy, the most useful first step is a conversation with a healthcare provider who knows your history. There is no need to rush or to navigate it alone. Our fertility support services page explains how care is structured, and a telemedicine consultation is a low-pressure way to ask questions.

If part of this landed hard, particularly the section on pregnancy loss, that reaction is understandable. Having someone to talk it through with helps.